¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"le cell test"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • chief cell
    À¸¶ä¼¼Æ÷
  • chromaffin cell
    Å©·Òģȭ¼¼Æ÷, ģũ·Ò¼¼Æ÷
  • chromophilic cell
    »ö¼Òµê¼¼Æ÷, È£»ö¼Ò¼¼Æ÷
  • chromophobic cell
    »ö¼Ò¾Èµê¼¼Æ÷
  • duct cell carcinoma
    °ü¼¼Æ÷¾ÏÁ¾
  • dust cell
    ¸ÕÁö¼¼Æ÷
  • delayed cell-mediated reaction
    Áö¿¬¼¼Æ÷¸Å°³¹ÝÀÀ
  • delta cell
    µ¨Å¸¼¼Æ÷
  • dendritic cell
    °¡Áö¼¼Æ÷, ¼öÁö»ó¼¼Æ÷
  • dark cell
    ¾îµÒ¼¼Æ÷
  • daughter cell
    µþ¼¼Æ÷
  • differentiated cell
    ºÐÈ­¼¼Æ÷
  • diffuse large B-cell lymphoma
    ±¤¹üÀ§Å«B¼¼Æ÷¸²ÇÁÁ¾
  • diploid cell
    µÎ¹è¼öü¼¼Æ÷
  • diploid cell line
    µÎ¹è¼öü¼¼Æ÷°è, À̹èü¼¼Æ÷°è
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • suprathreshold adaptation test
    ¹®ÅΰªÀ§ÀûÀÀ°Ë»ç, ¿ªÄ¡»ó¼øÀÀ¼Ò½Ç°Ë»ç
  • susceptibility test
    °¨¼ö¼º½ÃÇè
  • sweat test
    ¶¡°Ë»ç
  • swinging flashlight test
    ±³´ëºÒºû°Ë»ç
  • test strip
    °Ë»ç¶ì
  • turmeric test solution
    °­È²½ÃÇè¾×
  • test
    °Ë»ç, ½ÃÇè
  • tactual performance test
    Ã˰¢¼öÇà°Ë»ç
  • test type
    ½Ã°¢Ç¥, ½ÃÇ¥
  • three glass test
    ¼Â³ª´®´¢°Ë»ç
  • threshold tone decay test
    ¹®ÅΰªÃ»°¢ÇǷΰ˻ç, ¿ªÄ¡Ã»°¢ÇǷΰ˻ç
  • tone decay test
    û°¢ÇǷΰ˻ç
  • toxin neutralization test
    µ¶¼ÒÁßÈ­°Ë»ç
  • treadmill test
    Æ®·¹µå¹Ð°Ë»ç
  • triketohydrindene hydrate test
    ´ÑÈ÷µå¸°°Ë»ç
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • inner hair cell
    ³»À¯¸ð¼¼Æ÷
  • inner phalangeal cell
    ¼Ó¼Õ°¡¶ô¼¼Æ÷
  • inner pillar cell
    ³»ÁÖ¼¼Æ÷(¡­á¬øà).
  • inner pillar cell
    ¼Ó±âµÕ¼¼Æ÷
  • inner pillar cell
    ³»ÁÖ¼¼Æ÷
  • inner sustentacular cell
    ¼Ó¹öÆÀ¼¼Æ÷
  • insulin secreting islet cell tumor
    Àν¶¸° ºÐºñ¼º µµ¼¼Æ÷Á¾¾ç.
  • interaction, T-B cell
    T¼¼Æ÷-B¼¼Æ÷ »óÈ£ÀÛ¿ë
  • interaction, T-T cell
    T¼¼Æ÷°£ »óÈ£ÀÛ¿ë
  • persensitized cell
    °ú°¨ÀÛ¼¼Æ÷(ΦÊïíÂá¬øà)
  • petrous tip cell
    Ãßü÷ºÀ¼Ò.
  • photochemical cell
    ±¤È­ÇÐÀüÁö(ÎÃûùùÊ ï³ò®).
  • photoconductive cell
    ±¤Àüµµ¼ÒÀÚ(¡­áÈí­).
  • photoelectric cell
    ±¤ÀüÁö(ÎÃï³ò®).
  • physaliphorous cell
    ´ã°øÆ÷¼¼Æ÷(Ó½Íöøàá¬øà)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • epinephrine test
    ¿¡Çdz×ÇÁ¸°½ÃÇè.
  • erythrocyte antibody test
    ÀûÇ÷±¸Ç×ü½ÃÇè
  • erythrocyte antigen test
    ÀûÇ÷±¸Ç׿ø½ÃÇè
  • erythrocyte rosetting test
    ÀûÇ÷±¸·ÎÁ¬Çü¼º½ÃÇè
  • erythrocyte sedimentation test
    ÀûÇ÷±¸Ä§°­½ÃÇè.
  • esculin hydrolysis test
    ¿¡½ºÄ𸰰¡¼öºÐÇØ½ÃÇè
  • esterase test
    ¿¡½ºÅ×¶óÁ¦½ÃÇè
  • ethanol gelatin test
    ¿¡Å¸³îÁ©¶óƾ½ÃÇè
  • ethyl acetate test
    ¾Æ¼¼Æ®»ê ¿¡Æ¿½ÃÇè.
  • evoked otoacoustic emission test
    À¯¹ßÀÌÀ½Çâ¹æ»ç °Ë»ç
  • exercise stress test
    ¿îµ¿ºÎÇϰ˻ç
  • exercise stress test
    ¿îµ¿ºÎÇϰ˻ç(ê¡ÔÑݶùÃËþÞÛ).
  • exercise stress test
    ¿îµ¿ºÎÇϰ˻ç.
  • exercise stress test
    ¿îµ¿ºÎÇϰ˻ç
  • exercise test
    ¿îµ¿°Ë»ç(ê¡ÔÑËþÞÛ).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 20
EAST elevated-arm stress test; Emory angioplasty vs. surgery trial; external rotation, abduction stress t...
ET educational therapy; effective temperature; ejection time; embryo transfer; endothelin; endotoxin; e...
FAST flow-assisted, short-term [balloon catheter]; fluorescent antibody staining technique; fluoro-allerg...
FAT family attitudes test; fluorescent antibody technique; fluorescent antibody test
GAT gelatin agglutination test; geriatric assessment team; Gerontological Apperception Test; group adjus...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 20
IHAT Indirect Haemagglutination Test
IIF Indirect Immunofluorescence test
IHLT Indirect haemolysis test
ITT Insulin Tolerance Test
ICT Intra Oral Cariogenicity Test
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • residential cell
    Á¤ÁÖ ¼¼Æ÷
  • reticulum cell
    ¼¼¸Á ¼¼Æ÷
  • retinal cell
    ¸Á¸· ¼¼Æ÷
  • rheumatoid arthritis cell
    ·ù¸¶ÅäÀÌµå °üÀý¿° ¼¼Æ÷
  • Rieder's cell
    ¸®ÀÌ´õ ¼¼Æ÷
    ¾î¶² Á¾·ùÀÇ °ñ¼º ¹éÇ÷º´ Áß¿¡¼­ ³ªÅ¸³ª´Â ºÐÈ­µÇÁö ¾ÊÀº °ñºÎ¾Æ±¸·Î¼­, ¿øÇüÁúÀº û»öÀ¸·Î ÁøÇÏ°Ô ¿°»öµÇ°í, ÇÙÀº ½ÉÇÑ ÇԿ並 ³ªÅ¸³»¸ç, ¸¶Ä¡ ºÐ¿± ÇÙ°ú ºñ½ÁÇÑ ÇüŸ¦ ³ªÅ¸³»´Â °ÍÀÌ Æ¯Â¡ÀÌ´Ù.
  • rod cell
    °£»ó ¼¼Æ÷
    ´«ÀÇ ¸Á¸·¿¡¼­ ºûÀ» °¨ÁöÇÏ´Â ¼¼Æ÷. ºÀ»ó ¼¼Æ÷, °£»óü, °£Ã¼¶ó°íµµ ÇÑ´Ù. ¸·´ë ¸ð¾çÀ» Çϰí ÀÖ¾î, ¿µ¾î·Î ·Îµå
  • RVM off-cell
    Àüº¹Ãø ¿¬¼ö Áß´Ü ¼¼Æ÷
  • S : SulfurÀÇ ¾àÀÚ.

    S cell

    S ¼¼Æ÷
    ½Ã½ºÅ×ÀÎ
  • Sala's cell
    »ì¶ó ¼¼Æ÷
    ½É¸· ³»¿¡ À§Ä¡ÇÏ´Â °¨°¢ ½Å°æ ¸»´ÜÀ» Çü¼ºÇÏ´Â ¼¶À¯ ³» °áÇÕ Á¶Á÷ÀÇ ¼º»ó ¼¼Æ÷.
  • Schwann cell cytoplasm
    Schwann ¼¼Æ÷Áú
  • Schwann's cell
    ½´¹Ý ¼¼Æ÷
    ¼öÃÊÀý¿¡ Çϳª¾¿ ¹èÄ¡µÇ¸ç, ¶÷ºñ¿¡ ±³·û¿¡¼­ ³¡³­´Ù. ¸»ÃÊ¿¡¼­ ¼öÃʳª ½´¹ÝÃʸ¦ Çü¼ºÇÑ´Ù.
  • second-order cell
    ÀÌÂ÷ ¼¼Æ÷
  • secretory cell
    ºÐºñ ¼¼Æ÷
  • seminoma cell
    Á¤»ó ÇÇÁ¾ ¼¼Æ÷
    °íȯÀÇ ÀüÇüÀû Á¤»óÇÇÁ¾¿¡¼­ ³ªÅ¸³ª´Â Ä¿´Ù¶õ µÕ±Ù ¼¼Æ÷·Î¼­ dzºÎÇÑ ¼¼Æ÷ÁúÀÇ Áß¾Ó¿¡ 1°³ ȤÀº ±× ÀÌ»óÀÇ ÇÙ¼Òü¸¦ °¡Áø ºñ±³Àû Å« ÇÙÀ» °®°í ÀÖ´Ù.
  • sensitized cell
    °¨ÀÛ Ç÷±¸
    ÀûÇ÷±¸¿¡ ´ëÇÑ Ç×ü¿Í ÀûÇ÷±¸¸¦ °áÇÕ½ÃŲ °Í.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
widal test <investigation> A test involving agglutination of typhoid bacilli when they are mixed with serum containing typhoid antibodies from an individual having typhoid fever, used to detect the presence of Salmonella typhi and s. Paratyphi.
Pronounced: vidal
(13 Nov 1997)
complementation-fixation test <investigation> A test for the presence of antibodies in a serum, based on whether an antigen and complement, when put together with some red blood cells, are able to destroy them. If the red blood cells are destroyed, then antibodies were not present to prevent it. If the red blood cells are not destroyed, then antibodies were present to combine with the antigen and bind the complement, making them unable to attack the red blood cells.
(09 Oct 1997)
complement-fixation test An immunological test for determining the presence of a particular antigen or antibody when one of the two is known to be present, based on the fact that complement is "fixed" in the presence of antigen and its specific antibody.
See: Bordet-Gengou phenomenon.
(05 Mar 2000)
plasmacrit test A serologic screening method used as an aid in the diagnosis of syphilis; after only a few drops of heparinised blood (obtained from a pricked finger) are collected in a special capillary tube, the capillary tube is centrifugated in order to collect plasma, which is then mixed with a 0.01-ml drop of antigen (cardiolipin previously treated with choline chloride as an anti-inhibitor, in order to avoid falsely negative results that may occur with nonheated plasma or serum). After mechanically agitating the antigen-plasma mixture for 4 min, the presence or absence of flocculation is observed. A positive result should not be regarded as conclusively diagnostic, but a negative result excludes the likelihood of syphilis.
(05 Mar 2000)
mucin clot test A test that reflects the polymerization of synovial fluid hyaluronate; a few drops of synovial fluid added to acetic acid form a clot; poor clot formation occurs in a variety of inflammatory conditions including septic arthritis, gouty arthritis, and rheumatoid arthritis.
Synonym: Ropes test.
(05 Mar 2000)
platelet aggregation test A test of the ability of platelets to adhere to each other and hence form a haemostatic plug to prevent bleeding; failure to aggregate occurs in several conditions, e.g., thrombasthenia, Von Willebrand's disease, and following administration of aspirin, phenylbutazone, and indomethacin; the test is conducted by quantitating the decrease in turbidity that occurs in platelet-rich plasma following the in vitro addition of one or several platelet-aggregating agents (e.g., ADP, epinephrine, or serotonin).
(05 Mar 2000)
Mulder's test A qualitative test for proteins; a yellow product is formed by reacting proteins with hot, concentrated nitric acid.
(05 Mar 2000)
multiple sleep latency test A test of the propensity to fall asleep, done by performing polysomnography during multiple brief opportunities to sleep.
(05 Mar 2000)
Wormley's test A test for alkaloids, by treating the solution with picric acid or a dilute iodine-potassium-iodide solution, the presence of alkaloids being shown by a colour reaction.
(05 Mar 2000)
mumps sensitivity test A skin test for sensitivity to mumps, in which inactivated mumps virus is used as antigen.
(05 Mar 2000)
mumps skin test antigen A sterile suspension of killed mumps virus in isotonic sodium chloride solution, used to determine susceptibility to mumps or to confirm previous exposure.
(05 Mar 2000)
Wurster's test A test for tyrosine; the substance is dissolved in boiling water and quinone is added; if tyrosine is present a ruby-coloured reaction takes place, the solution changing to brown after a few hours.
(05 Mar 2000)
contraction stress test A test used to evaluate foetal well-being by inducing contractions and analyzing the foetal heart rate response.
(05 Mar 2000)
coombs' test Haemagglutination test in which coombs' reagent (antiglobulin, or anti-human globulin rabbit immune serum) is added to detect incomplete (non-agglutinating, univalent, blocking) antibodies coating erythrocytes. The direct test is applied to red cells which have been coated with antibody in vivo (e.g., in haemolytic disease of newborn, autoimmune haemolytic anaemia, and transfusion reactions). The indirect test is applied to serum to detect the presence of antibody (e.g., in detection of incompatibility in cross-matching tests, detection and identification of irregular antibodies, and in detection of antibodies not identifiable by other means).
(12 Dec 1998)
point system test types A near-vision test chart in which the various test types are multiples of a point (1/72 inch), lower-case letters being one-half the designated point size; reading 4-point at 16 inches is normal, and is designated N-4.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 20
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 20
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 20
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 20
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 20
ÅëÇÕ°Ë»ö ¿Ï·á